OREGON HEALTH AND SCIENCE UNIVERSITY

Their core work

Oregon Health & Science University (OHSU) is a US academic medical center in Portland that combines a research university, hospital system, and specialized research institutes under one roof — making it one of the few places where fundamental biology and clinical medicine are tightly integrated. In the H2020 context, OHSU served as an international host institution for European researchers, contributing expertise in neurological diseases, cancer biology, metabolic disorders, and auditory neuroscience. Their participation in MSCA schemes reflects a transatlantic bridge role: a destination where EU-funded doctoral candidates and exchange researchers gain exposure to the US biomedical research environment. OHSU's Oregon Hearing Research Center also positions the institution in spatial hearing and auditory adaptation research, visible through the ALT project.

What they specialise in

How they've shifted over time

Both of OHSU's H2020 projects launched within a narrow 2015–2016 window, which limits any meaningful long-term trend analysis. The earlier project (Bio4Med) centered on biomedical doctoral training — brain disease, cancer, and metabolic disorders — while the second (ALT) shifted toward auditory perception and spatial hearing, suggesting breadth across neuroscience rather than a single disciplinary track. Because the recent-period keyword set is empty (ALT carried no tagged keywords) and no later H2020 projects followed, it is not possible to identify a post-2018 evolution from this dataset alone.

With only two early-period MSCA projects and no follow-on H2020 activity, OHSU appears to have engaged selectively with EU funding as an international mobility destination rather than building a sustained European research presence — potential collaborators should verify whether OHSU participates in Horizon Europe before approaching them.

How they like to work

OHSU participated exclusively as a third party in both projects, meaning they were brought into EU consortia as an international host rather than as a project-shaping partner. Their 27 unique consortium partners across 14 countries reflect the broad, multi-institution structure typical of MSCA doctoral and exchange networks, not a tight bilateral relationship. This pattern suggests OHSU is a valued but peripheral node — an international destination that adds transatlantic credibility and research access to a consortium without driving its scientific agenda.

OHSU has connected with 27 unique consortium partners across 14 countries through just two projects — a relatively wide reach that reflects the large, multi-partner structure of MSCA schemes rather than a deliberate bilateral focus. No repeated partner clusters are identifiable from this data, consistent with the one-off nature of MSCA mobility grants.

What sets them apart

As a US-based academic medical center, OHSU offers EU consortia something most European partners cannot: a transatlantic research environment where European researchers gain direct experience in the US healthcare and biomedical ecosystem. Its combination of hospital, medical school, and dedicated research institutes under one roof makes it especially relevant for projects bridging fundamental biology and clinical application. For MSCA consortium builders seeking a credible American host with recognized strength in neuroscience and cancer biology, OHSU is a well-established name.

Highlights from their portfolio

• Bio4Med
  A five-year MSCA-COFUND doctoral programme (2015–2020) covering brain disease, cancer, and metabolic disorders — OHSU's most substantive EU engagement and the project with the richest keyword evidence for their biomedical expertise.
• ALT
  An MSCA-RISE exchange project on spatial hearing adaptation (2016–2019) that reveals a second research dimension beyond biomedicine, tied to OHSU's internationally recognized Oregon Hearing Research Center.